Newsroom
January 19, 2021
Miguel O. Beltrán-Delgado Joins Bioventus as Senior Vice President of Operations
DURHAM, NC – January 19, 2021 – Bioventus, a global leader in Innovations For Active Healing, has appointed Miguel O. Beltrán-Delgado as Senior Vice…
November 18, 2020
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
DURHAM, NC – November 18, 2020 – Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
November 16, 2020
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy
DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President…
November 10, 2020
Bioventus to Provide CVS Caremark with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief
DURHAM, NC – November 10 – Beginning January 1, 2021 Bioventus, a global leader in Innovations For Active Healing, will gain preferred access through…
September 22, 2020
Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
DURHAM, NC – September 22, 2020 – Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than…
September 2, 2020
Bioventus Reports First Use of its SIGNAFUSE Bioactive Bone Graft in Strip Format
DURHAM, NC – September 2, 2020 – Bioventus is sharing results of the first in-patient use of its new SIGNAFUSE Bioactive Bone Graft strips. Rick…
August 24, 2020
Bioventus Appoints Katrina Church Chief Compliance Officer
DURHAM, NC – August 24, 2020 – Bioventus, a global leader in orthobiologic solutions, has appointed Katrina Church as its Chief Compliance Officer,…
August 13, 2020
Hyaluronic Acid Provides Knee OA Pain Relief with Lower Costs, Fewer Adverse Outcomes vs. Corticosteroids or Knee Arthroplasty
DURHAM, NC – August 13, 2020– Intra-articular hyaluronic acid (IHA) knee osteoarthritis (OA) pain relief treatments had lower total medical care…
July 16, 2020
Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone Achievements
KFAR SABA, ISRAEL and DURHAM, NC– July 16, 2020 – CartiHeal, developer of the proprietary Agili™-C implant for the treatment of joint surface lesions…
June 25, 2020
Bioventus Receives FDA Clearance of Strip Format of its SIGNAFUSE Bioactive Bone Graft
DURHAM, NC – June 25, 2020 – Bioventus, a global leader in orthobiologic solutions, is launching its SIGNAFUSE Bioactive Bone Graft in a new strip…
Search News
Media Inquiries
Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]
Download Library
Corporate and Brand Logos
Download Now
Product Images
Download Now
